GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Cash Flow for Lease Financing

Medicure (TSXV:MPH) Cash Flow for Lease Financing : C$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Medicure Cash Flow for Lease Financing?

Medicure's Cash Flow for Lease Financing for the three months ended in Dec. 2023 was C$0.00 Mil. Medicure's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Sep. 2023 ), Medicure's Cash Flow for Lease Financing remained the same in Dec. 2023 (C$0.00 Mil).

Medicure Cash Flow for Lease Financing Historical Data

The historical data trend for Medicure's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Cash Flow for Lease Financing Chart

Medicure Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow for Lease Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medicure Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Medicure Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicure Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Medicure's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure (TSXV:MPH) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Cash Flow for Lease Financing
Comparable Companies
XCNQ:IMCC TSXV:CANB NEOE:FH XCNQ:RVV TSXV:DHB TSXV:HASH TSX:VPH TSX:WLLW XCNQ:XTRX TSX:CTX ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XTAE:TEVA XSWX:SDZ VTRS SZSE:000538 NBIX
Traded in Other Exchanges
MCUJF:USA NGQ1:Germany
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Website
https://www.medicure.com
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines